Clinical Trials Browser

NIH × Inflammatory Breast Neoplasms × Bevacizumab × Clear all

NCT00016549 2017-07-02

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms